News und Analysen
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
Many investors have flocked to big pharma stocks throughout the years. And doing so has paid off handsomely with several of those stocks.
AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) stand out as
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
In the gene editing therapies space, there aren't any competitors being watched more closely than Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP). The pair scored
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
In the gene editing therapies space, there aren't any competitors being watched more closely than Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP). The pair scored
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
In the gene editing therapies space, there aren't any competitors being watched more closely than Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP). The pair scored
Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support
Leading health and well-being company Humana today announced a meaningful investment of $500,000 in the Virginia Health Care Foundation (VHCF). This funding will bolster crucial behavioral health
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
5 Dividend Stocks That Recently Increased Their Payouts
My favorite stocks to invest in are those that continuously increase their dividend. Merck & Co (NYSE: MRK) is one stock that I like a lot that has been growing its dividend at a solid clip for a
EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
EQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist
Are we currently in a bull market? Some argue that we are. In early June, the S&P 500 closed 20% up from its most recent low, which is the technical definition of a bull market. However, equities
Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced the recipients of its first-ever research grants in service of the Foundation’s health
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF) empire, commercializing four drugs for the
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF) empire, commercializing four drugs for the
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF) empire, commercializing four drugs for the
Is Pfizer Stock a Buy Now?
Stocks have rallied this year, but one of the world's most famous pharma companies didn't join the party. Pfizer (NYSE: PFE), known for its billion-dollar coronavirus products -- the vaccine
Is Pfizer Stock a Buy Now?
Stocks have rallied this year, but one of the world's most famous pharma companies didn't join the party. Pfizer (NYSE: PFE), known for its billion-dollar coronavirus products -- the vaccine
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
As the year comes to an end, it's time to think about which stocks to sell for tax-loss harvesting. One stock I'm considering letting go is pharma giant Pfizer (NYSE: PFE). The company's shares have
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
As the year comes to an end, it's time to think about which stocks to sell for tax-loss harvesting. One stock I'm considering letting go is pharma giant Pfizer (NYSE: PFE). The company's shares have
2 Dividend Stocks to Buy and Hold Forever
Over long periods, dividend stocks tend to outperform their non-dividend-paying counterparts. There are likely several reasons for this, one of which is that sustaining a dividend program requires a
Is Novavax Stock a Buy Now?
Biotech company Novavax (NASDAQ: NVAX) went from being relatively unknown just four years ago to becoming one of the U.S. COVID-19 vaccine market leaders. The company has faced many trials and
Why Pfizer Stock Is Sinking Today
Shares of Pfizer (NYSE: PFE) were sinking 4.4% lower as of 11:10 a.m. ET on Friday after falling as much as 7.1% earlier in the morning. The sell-off came after the company announced that it's
Why Pfizer Stock Is Sinking Today
Shares of Pfizer (NYSE: PFE) were sinking 4.4% lower as of 11:10 a.m. ET on Friday after falling as much as 7.1% earlier in the morning. The sell-off came after the company announced that it's